Oct 20 (Reuters) – Drug developer Lycia Therapeutics said on Tuesday it was targeting a valuation of up to $937.7 million in its US initial public offering, as biotech companies flock to the IPO market. The South San Francisco, California-based company is seeking to raise up to $264.6 million in the
Oct 20 (Reuters) – AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other measures, as the drugmaker looks to improve clinical research. • The collaboration will combine AstraZ
By Nicholas P. Brown NEW YORK, Oct 20 (Reuters) – For Allison Vecchio, 42, GLP-1 drugs were “a reset button on life,” but at a price — side effects like gastrointestinal distress, brittle nails, and feelings of weakness so intense that at times she could not leave her bed. But the Fort Pierce, Flori
Oct 19 (Reuters) – Haemonetics said on Monday the US Food and Drug Administration approved its device designed to seal arterial openings created during minimally invasive heart and vascular procedures. Shares of the medical technology company rose about 1.2% in extended trading. • The device, PerQse
By Dietrich Knauth Oct 19 (Reuters) – California Attorney General Rob Bonta on Monday announced the state will receive a $6 million settlement payment in 23andMe’s bankruptcy, resolving California’s legal claims related to a 2023 data breach that exposed 6.9 million customers’ genetic and other pers
Oct 19 (Reuters) – The Pennsylvania Health Department on Monday reported 1,286 measles cases in the state, up 26 cases from the last update on Friday, as the outbreak of the highly contagious disease continues. Here are key details: • Measles-related hospitalizations this year stood at 247, accordin
Oct 19 (Reuters) – Unilever said on Monday it has agreed to sell Welly Health PBC to private-equity firm Forward Consumer Partners, but did not disclose financial terms of the sale. The consumer products giant had acquired a majority stake in the US brand, known for its colorful adhesive bandages, i
BRASILIA/SAO PAULO, Oct 19 (Reuters) – Brazil has detected a case of Newcastle disease at a turkey farm in the southern state of Santa Catarina, Agriculture Minister Andre de Paula said on Monday, raising concerns about potential disruptions to poultry shipments from the world’s largest chicken meat
By Trevor Hunnicutt and Ahmed Aboulenein WASHINGTON, Oct 19 (Reuters) – US President Donald Trump signed an executive order alongside first lady Melania Trump on Monday creating a White House task force and a National Institutes of Health division focused on women’s health. The task force will be le
By Christy Santhosh Oct 19 (Reuters) – German drugmaker Merck KGaA said on Monday it would acquire UK-based Silence Therapeutics in an all-cash deal for about $1.3 billion, bolstering its pipeline of precision medicines and adding RNA-targeting drug technology. Merck will pay $20 per American deposi
By Padmanabhan Ananthan Oct 19 (Reuters) – Disc Medicine said on Monday its experimental pill for a rare disease helped patients spend more time in sunlight without pain, sending its shares surging 35% in early trading. The late-stage trial success sets the stage for Disc to resubmit its application
Oct 19 (Reuters) – EyePoint on Monday said it would cut about 53% of its workforce and stop studies of its experimental drug for an age-related vision disease after a second late-stage trial failed. Its shares tanked more than 75% in premarket trading. • The trial tested EyePoint’s Duravyu against R
By Sneha S K Oct 19 (Reuters) – Drug developer Veradermics said on Monday that its oral pill helped increase hair growth in men with pattern hair loss in a late-stage study. Shares of the company were up 7.5% at $117 in premarket trading. Here are more details: • The company was testing its oral min
Oct 19 (Reuters) – Gilead Sciences said on Monday its experimental once-daily pill reduced symptoms of a chronic bowel illness in more patients than placebo in a mid-stage trial. • The drug, emvistegrast, was being tested in adults with moderate to severe ulcerative colitis, a chronic condition that
Oct 19 (Reuters) – Hong Kong-listed Metis TechBio said on Monday it has entered into a collaboration agreement with Eli Lilly worth up to $1.1 billion to research and develop tissue-specific drug delivery technologies. The Chinese biotech will use its proprietary AI-driven drug-delivery platform to
By Nichiket Sunil and Patrick Wingrove Oct 19 (Reuters) – China’s Hansoh Pharmaceutical said on Monday it has entered into a partnership and licensing deal with Roche potentially worth more than $15 billion that covers a portfolio of antibody-drug conjugate programs. As part of the deal with the Swi
FRANKFURT, Oct 19 (Reuters) – Swiss drugmaker Roche is reviewing all future investments in Germany over healthcare cost-cutting policies, the company’s Germany chief said in an interview with newspaper Welt published on Monday. “We have put all future investment decisions in Germany on hold for the
Oct 19 (Reuters) – Primary Health Properties expects to receive £500 million ($666.55 million) from a joint venture deal with Singapore sovereign wealth fund GIC that would help the British healthcare REIT cut debt, the firm said on Monday. Here are more details: • The partners will each own a 50% s
BERLIN, Oct 19 (Reuters) – Roche said on Monday it will present new late-stage trial results at the ESMO 2026 cancer meeting in Madrid, including data showing its lung cancer drug divarasib worked better than current KRAS G12C treatments. The company will also show data that its breast cancer pill g
Oct 18 (Reuters) – India will reduce the prices of as many as 137 cancer drugs by 70%, the Ministry of Chemicals and Fertilizers said on Saturday, as it widened price controls in a bid to make treatment more affordable. Trade margins on the drugs will be limited to 30% of the maximum retail price, t
By Yasmeen Abutaleb Oct 18 (Reuters) – North Carolina hasn’t elected a Democrat to the US Senate in nearly 20 years, but former Governor Roy Cooper has built a double-digit lead over Republican Michael Whatley by relentlessly focusing on affordability and a blunt promise to “make stuff cost less.” A
Oct 18 (Reuters) – The Ebola outbreak in Democratic Republic of Congo has spread to an eighth province, North Ubangi, Congo’s public health institute said on Sunday, confirming earlier Reuters reporting. The emergence of cases in the province, which borders Central African Republic, poses a new chal
(Undated) — A new study is shinning a light on teens and anxiety. According to the study, published in JAMA Pediatrics, about one in six teens surveyed have reported moderate to severe anxiety. It also reports that nearly two-thirds of adolescents who reported severe anxiety symptoms also met criter
(Bend, OR) — Police are praising some heroes after three children and a teacher were killed in a shooting at an elementary school in Oregon Thursday. In a Friday update, Bend Police Chief Mike Krantz noted the bravery of a teacher, who wrestled with the shooter, and of a 36-year-old dad who shot and
Oct 17 (Reuters) – Kenya confirmed four new cases of the Ebola Bundibugyo virus on Saturday, including three health workers who treated the country’s first patient, bringing the total number of confirmed cases to seven, the health ministry said. The other new case is a male relative of the index pat
Oct 17 (Reuters) – India’s food safety regulator on Saturday proposed a ban on adding sucrose and fructose to food products for infants up to six months of age, tightening rules on added sugars in infant nutrition products. Under existing rules, lactose and glucose polymers are the preferred carbohy
(Undated) — The Northeastern U.S. is getting a blast of severe weather. A cold front is bringing damaging winds of up to 70 miles-per-hour for millions today along with heavy rain and thunderstorms. Behind the front will be the coldest air the region has experienced so far this fall. The season’s fi
Oct 16 (Reuters) – Shah Capital, one of Novavax’s top shareholders, said on Friday it no longer seeks to influence control of the vaccine maker after restructuring into a family office. • The investor has filed with the US Securities and Exchange Commission to voluntarily withdraw its registration a
Oct 16 (Reuters) – Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a serious kidney condition, citing “strategic considerations”, according to a federal clinical trials registry. • The trial was evaluating whether the oral medication was safe and
NAIROBI, Oct 16 (Reuters) – Kenya reported its third Ebola infection on Friday, in a woman it said was closely related to the first two patients. The 65-year-old had been in quarantine since October 6, the health ministry said in a statement. “Once she developed fever, sore throat and malaise, she w
